Watson Pharmaceuticals News

A Los Angeles-based biotechnology company on Wednesday unveiled a new $70 million Phoenix manufacturing site that will create up to 200 technology jobs.

Watson Pharmaceuticals, Inc. earned $0.54 per share in the third quarter of 2009, down from $0.60 in the same quarter of last year.

MORRISTOWN,A N.J. Profits for generic drug maker Watson Pharmaceuticals got a big boost during third quarter 2009, jumping to $76.1 million from third quarter 2008a TMs $54 million, the company announced in an earnings report.

Watson Pharmaceuticals, Inc. today reported net income of $63.0 million, or $0.55 per diluted share for the third quarter ended September 30, 2009.

Drug developer Watson Pharmaceuticals Inc. said Wednesday its profit fell 11 percent in the third quarter as higher taxes and charges offset a revenue boost.

Watson Pharmaceuticals Inc. on Wednesday reported that its profits declined in the third quarter, as the company invested in launching and marketing several new medications.

Exxon Mobil Chemical's /quotes/comstock/13*!xom /quotes/nls/xom affiliate TonenGeneral said Wednesday it's launching a 50-50 joint venture with Toray Industries to develop products for the battery separator film business.

R. Todd Joyce has been named senior vice president and chief financial officer of Watson Pharmaceuticals , effective immediately.

Watson Pharmaceuticals today announced that R. Todd Joyce has been named Senior Vice President and Chief Financial Officer effective immediately.

Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced today that its subsidiary Watson Laboratories, Inc.

Watson Pharmaceuticals, Inc., a specialty pharmaceutical company, announced today that its subsidiary Watson Laboratories, Inc.

Our analysts have issued complimentary analysis on the following six companies: Watson Pharmaceuticals Inc.

The plan to shut the Watson Laboratories plant on Stoneleigh Avenue pushed forward this week as the company announced another round of layoffs.

Watson Pharmaceuticals, Inc. , a leader in generic and specialty branded pharmaceuticals, announced findings of a double-blind study which demonstrate that GELNIQUE was comparable to placebo in its effect on memory tests and other cognitive functions in older healthy adult subjects when compared to immediate release oral oxybutynin treatments.

MORRISTOWN, N.J. A generic pharmaceutical company has appointed a new executive to its branded drug division.

The retrial of Alabama's prescription drug overpricing lawsuit against California-based Watson Pharmaceuticals has been delayed.

Most recently, Wilkinson served as president and chief operating officer of Duramed Pharmaceuticals Inc, a subsidiary of Barr Pharmaceuticals Inc.

Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, today announced that Paul Bisaro, Watson's president and chief executive officer, will provide an overview and update of the Company's business at the Bank of America Merrill Lynch Global Healthcare Conference on Tuesday, September 15, 2009 at 2:30 p.m. . An archived ...

Whether it's a matter of ignorance or greed, people are still buying General Motors stock, even though the company and the government have warned that the shares will someday be worthless.

MORRISTOWN,A N.J. Watson Pharmaceuticals on Friday announced that its subsidiary, Watson Laboratories, has received approval from the Food and Drug Administration regarding its abbreviated new drug application for levonorgestrel for over-the-counter use in women ages 17 and above, as well as for prescription use in women under the age of 17.